Please try another search
On Friday, Oppenheimer adjusted its price target for Biogen (NASDAQ:BIIB), a biotechnology company, ahead of its first-quarter earnings report scheduled for April 24, 2024. The firm reduced the target...
On Friday, Oppenheimer adjusted its price target on shares of Equifax (NYSE:EFX) to $272 from the previous $291, while reaffirming its Outperform rating. This change follows the company's recent...
On Wednesday, Oppenheimer initiated coverage on Sprout Social Inc . (NASDAQ:SPT) with a positive outlook, assigning the stock an Outperform rating and setting a price target of $76. The firm's...
Bearish: Currently we are at 1.9345 in a well built channel. IF we can break support here, we are looking to continue to the ATR target @ 1.9262 with a further target the 1.270 Fibo @...
Is Nio Inc Class A ADR (NYSE:NIO) the opportunity of a lifetime?Although NIO's recent performance may seem disappointing, it is important to evaluate the company's performance in relation to the...
Gold rebounded after Friday's bearish close but another correction cannot be ruled out. Despite Friday's record high, gold faced selling pressure later, signaling possible short-term losses. Traders...
Instrument Type
Region
Sector
Industry
Date
Category
Provider